Efficacy and Safety of Precision Therapy in Refractory Tumor
Clinical trial NCT03239015 · UNKNOWN
Trial details
- NCT number
- NCT03239015
- Sponsor
- Baodong Qin
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2023-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.